Correction for Kovacs et al., "An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline"
Antimicrob Agents Chemother. 2020 Dec 16;65(1):e02426-20.
doi: 10.1128/AAC.02426-20.
Print 2020 Dec 16.